Cooke Shane
SEC insider (Form 3/4/5 filer). CIK 0001524823. Director at Alkermes plc. (ALKS) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on May 21, 2026. Located in DUBLIN.
Companies Cooke Shane has filed insider reports for
- Alkermes plc. (ALKS): Director
- PROTHENA CORP PUBLIC LTD CO (PRTA): Director
Cooke Shane
CIK: 0001524823
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- May 21, 2026ALKS
Alkermes plc.
Tax PaymentDirect3.2K shares at avg. $36.95$118K - May 21, 2026ALKS
Alkermes plc.
ExerciseDirect6.1K shares- - May 20, 2026ALKS
Alkermes plc.
AwardDirectNon Qualified Stock Option (Right to Buy)
11.5K shares- - May 20, 2026ALKS
Alkermes plc.
AwardDirectRestricted Stock Unit Award
5.4K shares- - May 20, 2026ALKS
Alkermes plc.
AwardDirectRestricted Stock Unit Award
5.4K shares- - May 20, 2026ALKS
Alkermes plc.
AwardDirectNon Qualified Stock Option (Right to Buy)
11.5K shares- - May 15, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
AwardDirectStock Option (Right to Buy)
27K shares- - Feb 2, 2026ALKS
Alkermes plc.
SaleDirect32.1K shares at avg. $34.78$1.1M - Feb 2, 2026ALKS
Alkermes plc.
SaleDirect29.1K shares at avg. $34.34$999K - Feb 2, 2026ALKS
Alkermes plc.
ExerciseDirect61.2K shares at avg. $31.64$1.9M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 | ALKS Alkermes plc. | Tax Payment | 3,207 | $36.95 | $118,499 | Direct |
| May 21, 2026 | ALKS Alkermes plc. | Exercise | 6,142 | - | $0 | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award Non Qualified Stock Option (Right to Buy) | 11,538 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award Restricted Stock Unit Award | 5,409 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award Restricted Stock Unit Award | 5,409 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award Non Qualified Stock Option (Right to Buy) | 11,538 | - | - | Direct |
| May 15, 2026 | PRTA PROTHENA CORP PUBLIC LTD CO | Award Stock Option (Right to Buy) | 27,000 | - | - | Direct |
| Feb 2, 2026 | ALKS Alkermes plc. | Sale | 32,113 | $34.78 | $1,116,877 | Direct |
| Feb 2, 2026 | ALKS Alkermes plc. | Sale | 29,087 | $34.34 | $998,795 | Direct |
| Feb 2, 2026 | ALKS Alkermes plc. | Exercise | 61,200 | $31.64 | $1,936,368 | Direct |
1-10 of 15 transactions